cisplatin,nivolumab
bms
['nivolumab', 'cisplatin', 'urothelial', 'check,mate,274', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'nivo']
#checkmate274 extended follow up is here (min fu 31.6 months)! stellar presentation by !
continued dfs, mfs and pfs2 benefit with nivolumab vs placebo
#gu23 
Senior Executive & Chief GU Cancers @DanaFarber; Prof Medicine @HarvardMed; 2021 Giants of Cancer Award ⚽ lover; 🚲@PanMass, seen on @msnbc @cnn @TODAYshow